| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.073 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |